Antibióticos nebulizados. ¿Una opción adecuada para el tratamiento de la infección respiratoria relacionada con la ventilación mecánica?

Masterton, 2008, Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy, J Antimicrob Chemother., 62, 5, 10.1093/jac/dkn162

Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC); Grupo de Trabajo de Enfermedades Infecciosas. Informe ENVIN/HELICS 2013. Estudio nacional de vigilancia de infección nosocomial en servicios de medicina intensiva. Disponible en: http://www.semicyuc.org/sites/default/files/envin-uci_infome13_0.pdf

Wunderink, 2011, Ventilator-associated tracheobronchitis: Public-reporting scam or important clinical infection, Chest, 139, 485, 10.1378/chest.10-2641

Klompas, 2013, Complications of mechanical ventilation. The CDC's new surveillance paradigm, N Engl J Med, 368, 1742, 10.1056/NEJMp1300633

Rodríguez, 2014, Incidence and diagnosis of ventilator-associated tracheobronchitis (VAT) in the intensive care unit: An international online survey, Crit Care., 18, R32, 10.1186/cc13725

Neuhauser, 2003, Antibiotic resistance among gram-negative bacilli in US intensive care units: Implications for fluoroquinolone use, JAMA., 289, 885, 10.1001/jama.289.7.885

Arias, 2009, Antibiotic-resistant bugs in the 21st century--A clinical super-challenge, N Engl J Med, 360, 439, 10.1056/NEJMp0804651

Nussenblatt, 2014, Ventilator-associated pneumonia: Overdiagnosis and treatment are common in medical and surgical intensive care units, Infect Control Hosp Epidemiol., 35, 278, 10.1086/675279

Palmer, 2009, Aerosolized antibiotic in critically ill ventilated patients, Curr Opin Crit Care, 15, 413, 10.1097/MCC.0b013e328330abcf

Klepser, 2004, Role of nebulized antibiotic for the treatment of respiratory infections, Curr Opin Infect Dis, 17, 109, 10.1097/00001432-200404000-00007

Palmer, 2011, Aerolized antibiotics in the Intensive Care Unit, Clin Chest Med, 32, 559, 10.1016/j.ccm.2011.05.012

Ramsey, 1993, Efficacy of aerosolized tobramycin in patients with cystic fibrosis, N Engl J Med., 328, 1740, 10.1056/NEJM199306173282403

Ramsey, 1999, Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group, N Engl J Med., 340, 23, 10.1056/NEJM199901073400104

Gibson, 2006, Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis, Pediatr Pulmonol., 41, 656, 10.1002/ppul.20429

Singh, 2000, Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms, Nature., 407, 762, 10.1038/35037627

Inglis, 1995, Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation, Chest, 108, 1049, 10.1378/chest.108.4.1049

Prince, 2002, Biofilms and antibiotic resistance, N Engl J Med, 347, 1110, 10.1056/NEJMcibr021776

Marr, 2007, The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and mortality, Microbiology, 153, 474, 10.1099/mic.0.2006/002519-0

Klick, 1975, Prevention of gram-negative bacillary pneumonia using polymyxin aerosol as prophylaxis. Effect on the incidence of pneumonia in seriously ill patients, J Clin Invest., 55, 514, 10.1172/JCI107957

Feeley, 1975, Aerosol polymyxin and pneumonia in seriously ill patients, N Engl J Med, 293, 471, 10.1056/NEJM197509042931003

Badia, 2004, Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients, J Antimicrob Chemother., 54, 508, 10.1093/jac/dkh326

Luyt, 2009, Aerosolized antibiotics to treat ventilator-associated pneumonia, Curr Opin Infect Dis, 22, 154, 10.1097/QCO.0b013e328322a006

Goldstein, 2002, Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets, Am J Respir Crit Care Med., 166, 1375, 10.1164/rccm.200204-363OC

Goldstein, 2002, Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs, Am J Respir Crit Care Med., 165, 171, 10.1164/ajrccm.165.2.2107025

Niederman, 2007, Amikacin aerosol achieves high tracheal aspirate concentrations in intubated mechanically ventilated patients with Gram-negative pneumonia: A pharmacokinetic study, Am J Respir Crit Care Med, 175, A326

Le, 2010, Consensus summary of aerosolized antimicrobial agents: Application of guideline criteria. Insights from the Society of Infectious Disease Pharmacists, Pharmacotherapy, 30, 562, 10.1592/phco.30.6.562

Lu, 2011, Nebulized caftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa, Am J Respir Crit Care Med, 184, 106, 10.1164/rccm.201011-1894OC

Sobieszczyk, 2004, Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections, J Antimicrob Chemother, 54, 566, 10.1093/jac/dkh369

Kwa, 2005, Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa, Clin Infect Dis, 41, 754, 10.1086/432583

Palmer, 2008, Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit, Crit Care Med., 36, 2008, 10.1097/CCM.0b013e31817c0f9e

Palmer, 2014, Reduction of bacterial resistance with inhaled antibiotics in the Intensive Care Unit, Am J Respir Crit Care Med, 189, 1225, 10.1164/rccm.201312-2161OC